Correlation Between Monte Rosa and Blueprint Medicines
Can any of the company-specific risk be diversified away by investing in both Monte Rosa and Blueprint Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monte Rosa and Blueprint Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monte Rosa Therapeutics and Blueprint Medicines Corp, you can compare the effects of market volatilities on Monte Rosa and Blueprint Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monte Rosa with a short position of Blueprint Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monte Rosa and Blueprint Medicines.
Diversification Opportunities for Monte Rosa and Blueprint Medicines
0.56 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Monte and Blueprint is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Monte Rosa Therapeutics and Blueprint Medicines Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blueprint Medicines Corp and Monte Rosa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monte Rosa Therapeutics are associated (or correlated) with Blueprint Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blueprint Medicines Corp has no effect on the direction of Monte Rosa i.e., Monte Rosa and Blueprint Medicines go up and down completely randomly.
Pair Corralation between Monte Rosa and Blueprint Medicines
Given the investment horizon of 90 days Monte Rosa Therapeutics is expected to generate 2.23 times more return on investment than Blueprint Medicines. However, Monte Rosa is 2.23 times more volatile than Blueprint Medicines Corp. It trades about 0.03 of its potential returns per unit of risk. Blueprint Medicines Corp is currently generating about 0.06 per unit of risk. If you would invest 902.00 in Monte Rosa Therapeutics on August 28, 2024 and sell it today you would lose (56.00) from holding Monte Rosa Therapeutics or give up 6.21% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Monte Rosa Therapeutics vs. Blueprint Medicines Corp
Performance |
| Timeline |
| Monte Rosa Therapeutics |
| Blueprint Medicines Corp |
Monte Rosa and Blueprint Medicines Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Monte Rosa and Blueprint Medicines
The main advantage of trading using opposite Monte Rosa and Blueprint Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monte Rosa position performs unexpectedly, Blueprint Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blueprint Medicines will offset losses from the drop in Blueprint Medicines' long position.| Monte Rosa vs. Nkarta Inc | Monte Rosa vs. Lyell Immunopharma | Monte Rosa vs. Generation Bio Co | Monte Rosa vs. Sana Biotechnology |
| Blueprint Medicines vs. Eliem Therapeutics | Blueprint Medicines vs. HCW Biologics | Blueprint Medicines vs. Scpharmaceuticals | Blueprint Medicines vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |